Screener
Medpace Holdings, Inc. MEDP EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by Medpace Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The source filing: Medpace Holdings, Inc.’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001668397-26-000025
| (Amounts in thousands, except per share amounts) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Income tax provision | 30,301 | 34,278 | 54,022 | 37,853 |
| Net income | $121,362 | $90,260 | $245,232 | $204,855 |
| Net income per share attributable to common shareholders: | ||||
| Basic | $4.31 | $3.16 | $8.66 | $6.95 |
| Diluted | $4.25 | $3.10 | $8.53 | $6.79 |
| Weighted average common shares outstanding: | ||||
| Basic | 28,174 | 28,601 | 28,308 | 29,489 |
| Diluted | 28,554 | 29,143 | 28,761 | 30,165 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Medpace Holdings, Inc.'s EPS (basic)?
- Medpace Holdings, Inc. (MEDP) reported EPS (basic) of $4.31 in Q2 2026.
- How has Medpace Holdings, Inc.'s EPS (basic) changed year-over-year?
- Medpace Holdings, Inc.'s EPS (basic) increased by 36.4% year-over-year, from $3.16 to $4.31.
- What is the long-term trend for Medpace Holdings, Inc.'s EPS (basic)?
- Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s EPS (basic) has grown at a 32.6% compound annual growth rate (CAGR), from $5.06 to $15.64.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.
Ask your AI about Medpace Holdings, Inc.'s eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude